The Cellular Financial Statement: Decoding Your Health Through Urine Metabolomics

Health assessment is moving away from "one-size-fits-all" toward precision health. For decades, the blood panel has been the gold standard, and it remains essential for diagnosing acute disease, but it often misses the subtle, sub-clinical shifts in biochemistry that precede chronic illness.

Blood shows what's circulating: the body's "currency." Urine metabolomics, specifically the assessment of urinary organic acids, shows something different: the "waste" your cells produce as they work. vivaMETABOLITE shifts the focus from inputs to outputs, offering a window into mitochondrial health, gut activity, and cellular efficiency that a blood panel alone doesn't provide.

IN SHORT
Blood tests show your body's inputs; urine metabolomics shows its outputs. This urine-based test reveals mitochondrial efficiency, gut-derived compounds, nutrient status and oxidative stress, offering clues a standard blood panel can miss.

Why urine metabolomics adds a different lens

Blood is a tightly regulated environment. Your body will pull minerals from bone and nutrients from tissue to keep blood levels within a narrow "normal" range, which means a blood test can show a "normal" nutrient level even when your cells are functionally short of it.

Urine, by contrast, reflects metabolic flux more directly. As biochemical reactions occur within mitochondria and cytoplasm, they produce intermediate compounds called organic acids. When an enzyme is sluggish, due to genetic variation, nutrient deficiency, or other interference, these intermediates back up and are excreted in the urine.

Metabolomics is often described as closer to the "phenotype" than genomics: rather than showing what might happen (as DNA does), metabolites reflect what is happening at a cellular level right now.

1. Mitochondrial efficiency

Mitochondria generate ATP via the Krebs Cycle. When this process is inefficient, symptoms can include fatigue and reduced cognitive clarity. vivaMETABOLITE measures Krebs Cycle intermediates like citrate, succinate and fumarate.

• High levels of these acids are established markers used in identifying disruptions to the citric acid cycle and respiratory chain function [3].
• Identifying specific patterns allows for more targeted nutritional support than a generic "energy supplement."

2. Gut microbiome activity

While stool testing (vivaBIOME) identifies which bacterial species are present, urine metabolomics reflects what they're actually doing, since microbial fermentation byproducts are absorbed into the blood and excreted by the kidneys.

• Specific organic acids can indicate yeast or bacterial overgrowth.
• These microbial byproducts can influence host enzymes and are linked to effects beyond the gut, connecting gut activity to broader biochemistry in a way standard tests don't capture.

3. Neurotransmitter turnover

Dopamine and serotonin break down into specific metabolites, including HVA and 5-HIAA. vivaMETABOLITE also assesses the kynurenine pathway: under systemic stress, the amino acid tryptophan is diverted away from serotonin production and toward quinolinic acid.

• Quinolinic acid is a neurotoxin linked to overstimulation of brain cells, associated with symptoms like brain fog [4].
• Elevated levels of these metabolites are linked to systemic immune activation.

4. Functional nutrient status

Standard nutrition testing relies on serum levels, which don't always reflect tissue-level status. Organic acid testing offers a functional view instead.

• Vitamin B12: rather than measuring B12 directly, methylmalonic acid (MMA) is used as a marker; elevated MMA is a more sensitive indicator of functional B12 deficiency than serum B12 levels [6].
• B-vitamin cofactors: similar functional markers exist for folate and B6, supporting supplementation targeted to what your biochemistry indicates you need [1].

5. Detoxification capacity and oxidative stress

Detoxification capacity depends partly on antioxidants like glutathione. vivaMETABOLITE assesses this via markers of oxidative damage.

• DNA damage: 8-OHdG (8-hydroxy-2'-deoxyguanosine) is a recognised biomarker for oxidative stress to DNA [7].
• Elevated 8-OHdG is linked to reduced antioxidant capacity and is associated with increased risk of conditions including atherosclerosis and diabetes, as well as accelerated ageing [8].

Bringing the pillars together

The value of vivaMETABOLITE lies in synthesising these five areas into a single picture rather than treating gut, brain and mitochondria as separate systems. For example, high quinolinic acid (neuro-inflammation) alongside high HPHPA (a Clostridia-linked marker) and low succinate (a mitochondrial marker) together suggest a gut-derived compound contributing to systemic inflammation that may be affecting both brain function and cellular energy production.

vivaOS, vivaLAB's AI health intelligence platform, helps connect these patterns across your results, moving the focus from managing symptoms in isolation toward understanding what your own biochemistry is showing.

See what your cells are telling you
A vivaINSIGHT test includes vivaMETABOLITE, covering 50+ consumer markers across energy production, nutrient status, gut-derived compounds and oxidative stress. vivaBALANCE 360 retests at 4 and 9 months to track change.

vivaLAB's services are designed to support health optimisation and are not a substitute for medical advice. Consult a qualified health practitioner for individual health decisions.

References:

1. Herrmann, W., Obeid, R., Schorr, H., & Geisel, J. (2003). Functional vitamin B12 deficiency and determination of holotranscobalamin in populations at risk. Clinical Chemistry and Laboratory Medicine, 41(11), 1478-1488. PMID: 14656029.
2. Barshop, B. A. (2004). Metabolomic approaches to mitochondrial disease: correlation of urine organic acids. Mitochondrion. PMID: 16120414.
3. Alban, C., et al. (2017). The relationship between mitochondrial respiratory chain activities and metabolites in urine. Journal of Clinical Medicine. PMID: 28304343.
4. Lugo-Huitrón, R., Ugalde Muñiz, P., Pineda, B., Pedraza-Chaverrí, J., Ríos, C., & Pérez-de la Cruz, V. (2013). Quinolinic acid: an endogenous neurotoxin with multiple targets. Oxidative Medicine and Cellular Longevity, 2013, 104024. PMID: 24089628.
5. Pathak, S., et al. (2024). The influence of kynurenine metabolites on neurodegenerative pathologies. International Journal of Molecular Sciences. PMID: 38255926.
6. Vashi, P., et al. (2016). Methylmalonic acid and homocysteine as indicators of B-12 deficiency. PLOS ONE. PMID: 26808123.
7. Wu, L. L., et al. (2004). Urinary 8-OHdG: a marker of oxidative stress to DNA. Clinica Chimica Acta. PMID: 14711444.
8. Valavanidis, A., et al. (2009). 8-OHdG: a critical biomarker of oxidative stress and carcinogenesis. Journal of Environmental Science and Health. PMID: 19444693.